Merck Marketing, Pricing Practices Lead To Settlement With Justice Dept.
Executive Summary
Merck's $650 million settlement with the Department of Justice to resolve state and federal investigations into payment of Medicaid rebates and incentives to health care workers will act as a deterrent to other drug makers, the agency said
You may also be interested in...
Vioxx Settlement Down, Merck Has Three More Government Probes Pending
Sales rep call notes on Vioxx off-label promotion were a key part of the government’s criminal case against Merck; $950 million settlement includes a new corporate integrity agreement that requires monitoring of call notes.
Another Vioxx Settlement, Another Must-Do List For Merck
Merck has settled Vioxx shareholder derivative litigation by agreeing to implement a host of corporate governance changes. Among the new requirements, Merck must run ads in medical journals publicizing its clinical trial registry, post reviews of its compliance procedures, and create two safety committees
Another Vioxx Settlement, Another Must-Do List For Merck
Merck has settled Vioxx shareholder derivative litigation by agreeing to implement a host of corporate governance changes. Among the new requirements, Merck must run ads in medical journals publicizing its clinical trial registry, post reviews of its compliance procedures, and create two safety committees